Pelentan

Anticoagulant drug Pelentan

The drug presented above is an indirect anticoagulant. It belongs to the group of anticoagulant drugs that slow down blood clotting and prevent the formation of blood clots. Pelentan is produced under the brand name Havrepharma in the form of tablets weighing 500 mg and is represented by two manufacturers: the Czech pharmaceutical company LECHIVA and its subsidiary Spofa Prague.

Composition of the drug Pelentan The drug contains the active substance ethylbuscumacetate, also known as Neodicumarine, which is an indirect ocatnuant. 1 tablet of the drug contains 300 milligrams of ethylbuscamacetate. The drug is produced in special cell blisters containing 1, 10 or 10 tablets. Blisters are packaged either in single packs or in packs containing 5 or 9 blisters. Cardboard packaging includes from 5 to 40 such blister packs. Each package contains a label with the inscription "INN (International Nonproprietary Name): Ethyl bis-coumacetate", confirming the international status of the product and its compliance with pharmaceutical and pharmacological standards.